Shang­hai Bao, Sichuan Biokin file IPOs in Hong Kong; Dis­c's $200M of­fer­ing

Plus, news about Rivus and Crown Labs:

Two Chi­nese biotechs file for stock list­ings in Hong Kong: Shang­hai Bao Phar­ma­ceu­ti­cals and Sichuan Biokin Phar­ma­ceu­ti­cal join …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER